cmd condition hsi (.xlsx)
Download original .xlsx file from GitHub
info
ResourceFile_cmd_condition_hsi |
|
---|---|
0 |
Created by Britta Jewell on 14 April 2021 |
1 |
|
2 |
This file reads in parameters for the HSI events (diagnostics and treatment) of each condition annually in the CMD module in the TLO model. Each tab represents one condition modelled. Where possible, sources are listed to the right of the parameter values. |
diabetes
parameter_name |
value |
Unnamed: 2 |
Unnamed: 3 |
|
---|---|---|---|---|
0 |
test_item_code |
216 |
Blood glucose level test |
|
1 |
sensitivity_of_assessment |
1 |
||
2 |
medication_item_code |
233 |
First line treatment (Metformin hydrochloride 500mg_100_CMST) |
|
3 |
pr_assessed_other_symptoms |
0.1 |
||
4 |
pr_treatment_works |
0.42 |
Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998, 352 (9131): 854-865. |
|
5 |
pr_diagnosed |
0.3846 |
Price et al. Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi. The Lancet Diabetes and Endocrinology 2018:6 208-22. |
|
6 |
pr_seeking_further_appt_if_drug_not_available |
0.8 |
hypertension
parameter_name |
value |
Unnamed: 2 |
Unnamed: 3 |
|
---|---|---|---|---|
0 |
sensitivity_of_assessment |
1 |
||
1 |
medication_item_code |
221 |
First line treatment (Hydrochlorothiazide 25mg_1000_CMST) |
|
2 |
pr_assessed_other_symptoms |
0.05 |
||
3 |
pr_treatment_works |
0 |
||
4 |
pr_diagnosed |
0.3797 |
Price et al. Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi. The Lancet Diabetes and Endocrinology 2018:6 208-22. |
|
5 |
pr_seeking_further_appt_if_drug_not_available |
0.8 |
chronic_lower_back_pain
parameter_name |
value |
Unnamed: 2 |
Unnamed: 3 |
|
---|---|---|---|---|
0 |
sensitivity_of_assessment |
1 |
||
1 |
medication_item_code |
226 |
Aspirin 300mg_1000_CMST |
|
2 |
pr_assessed_other_symptoms |
0 |
||
3 |
pr_treatment_works |
0 |
||
4 |
pr_diagnosed |
0 |
||
5 |
pr_seeking_further_appt_if_drug_not_available |
0.1 |
chronic_kidney_disease
parameter_name |
value |
Unnamed: 2 |
Unnamed: 3 |
|
---|---|---|---|---|
0 |
test_item_code |
47 |
||
1 |
pr_assessed_in_generic_appt_level1 |
1 |
||
2 |
medication_item_code |
2064 |
Dianeal + Dextrose 1.5% intraperitoneal dialysis soln. with minicap_2L_CMST |
|
3 |
pr_assessed_other_symptoms |
0 |
||
4 |
pr_treatment_works |
0 |
||
5 |
pr_diagnosed |
0.02 |
||
6 |
pr_seeking_further_appt_if_drug_not_available |
0.8 |
chronic_ischemic_hd
parameter_name |
value |
Unnamed: 2 |
Unnamed: 3 |
|
---|---|---|---|---|
0 |
sensitivity_of_assessment |
1 |
||
1 |
medication_item_code |
226 |
Aspirin 300mg_1000_CMST |
|
2 |
pr_assessed_other_symptoms |
0 |
||
3 |
pr_treatment_works |
0 |
||
4 |
pr_diagnosed |
0.05 |
||
5 |
pr_seeking_further_appt_if_drug_not_available |
0.8 |